C-reactive protein (CRP)2 is an acute phase reactant that is markedly increased during infection, inflammation, and tissue injury (1-5). It is synthesized and secreted mainly by the liver in response to circulating inflammatory mediators (6, 7). Elevated serum CRP levels serve as a risk marker for cardiovascular disease and predict future cardiovascular events and mortality (8, 9).Data obtained both in vivo and in vitro indicate that CRP plays a role in vascular inflammation (10 -12). CRP can be detected in human atherosclerotic plaques co-localized with modified low density lipoprotein (13,14). It can also associate with the terminal complex of complement in the arterial wall, inducing its activation in plaques. CRP promotes the uptake of low density lipoprotein by macrophages (15) and exerts a mitogenic effect on vascular smooth muscle cells (16). CRP stimulates chemokine and adhesion molecule expression in vascular endothelial cells and enhances platelet adhesion to endothelial cells (17). These data suggest that CRP is not just a marker of cardiovascular risk but is a risk factor in its own right, and CRP plays a causal role in atherosclerosis and thrombosis. In fact, transgenic overexpression of human CRP has been shown to promote atherosclerosis in apoE Ϫ/Ϫ mice (18), as does chronic administration (19). These data support an hypothesis that CRP is a proinflammatory and pro-atherogenic factor.Inflammation is an important component in all stages of atherosclerosis, with proinflammatory cytokines and chemokines playing critical roles. IL-17 is a member of a novel group of proinflammatory cytokines that is composed of six major isoforms, IL-17A, -B, -C, -D, -E (also known as IL-25), and -F (20). These isoforms are encoded by unique genes and share little homology with other interleukins. IL-17 signals via IL-17 receptors, products of unique genes, and includes IL-17RA, -B (also known as IL-25R), -C, -D, and -E (20).IL-17A is the most widely studied cytokine of the IL-17 family. It signals via IL-17RA and exerts proinflammatory, pro-apoptotic, and pro-mitogenic effects. Unlike IL-17, which is considered a T-cell-specific cytokine (21), many cell types in the body express the receptors and are therefore targets of . In this study we investigated whether IL-17 stimulates CRP expression in human hepatocytes and CASMC, and we determined the signal transduction pathways involved in * This work was supported in part by the Research Service of the Department of Veterans Affairs and NHLBI Grant HL68020 from the National Institutes of Health (to B. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed: Medicine/Cardiology,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.